Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients.

Transplantation proceedings - 1 Nov 2012

Torio A, Auyanet I, Montes-Ares O, Guerra R M, Fernandez E J, Perez M A, Ramirez A, Checa M D

Abstract excerpt

BACKGROUND: The cytochrome P450 3A5 (CYP3A5) enzyme has been implicated to determine blood pressure (BP) in humans. Different results have been reported concerning CYP3A5 gene polymorphisms and posttransplantation hypertension in kidney recipients. Our objective was to investigate whether CYP3A5 1/3 polymorphism was associated with ambulatory BP among a population of renal transplant recipients receiving the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Pressure Monitoring, Ambulatory

Share to Calcineurin Inhibitors

Share to Cytochrome P-450 CYP3A

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Tacrolimus

Source

Identifiers

PMID: 23146466
DOI: 10.1016/j.transproceed.2012.09.047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients.PMID 23146466Read ↗

Association between CYP3A5 polymorphisms and blood pressure in kidney transplant recipients receiving calcineurin inhibitors.Semantic proximity Read ↗

Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.Semantic proximity Read ↗

Pharmacogenetics of immunosuppressant polymorphism of CYP3A5 in renal transplant recipients.Semantic proximity Read ↗

The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients.Semantic proximity Read ↗

CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantation .Semantic proximity Read ↗

Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels.Semantic proximity Read ↗

CYP3A5 genotype is associated with elevated blood pressure.Semantic proximity Read ↗

The Prognostic Role of CYP Enzyme in Kidney Transplantation: A Single Centre Experience.Semantic proximity Read ↗

CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.Semantic proximity Read ↗

Association between renal function and CYP3A5 genotype in heart transplant recipients treated with calcineurin inhibitors.Semantic proximity Read ↗

Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus.Semantic proximity Read ↗

CYP3A5 polymorphism, amlodipine and hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.